Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Robert S Mittleman"'
Autor:
Claire Ervin, Lindsey Norcross, Usha G. Mallya, Sheri Fehnel, Robert S. Mittleman, Matthew Webster, Andrea M. Haqq, Robert M. Haws
Publikováno v:
Advances in Therapy. 40:2394-2411
Autor:
Andrea M, Haqq, Wendy K, Chung, Hélène, Dollfus, Robert M, Haws, Gabriel Á, Martos-Moreno, Christine, Poitou, Jack A, Yanovski, Robert S, Mittleman, Guojun, Yuan, Elizabeth, Forsythe, Karine, Clément, Jesús, Argente
Publikováno v:
The Lancet Diabetes & Endocrinology. 10:859-868
Impaired cilial signalling in the melanocortin-4 receptor (MC4R) pathway might contribute to obesity in patients with Bardet-Biedl syndrome and Alström syndrome, rare genetic diseases associated with hyperphagia and early-onset severe obesity. We ai
Autor:
Phebe J. Wilson, Margaret M. Redfield, Michael R. Zile, Albert T. Profy, John C. Burnett, Robert S. Mittleman, Jelena P. Seferovic, Gregory D. Lewis, Marvin A. Konstam, Sanjiv J. Shah, James E. Udelson, John D. Parker
Publikováno v:
JAMA
IMPORTANCE: Heart failure with preserved ejection fraction (HFpEF) is often characterized by nitric oxide deficiency. OBJECTIVE: To evaluate the efficacy and adverse effects of praliciguat, an oral soluble guanylate cyclase stimulator, in patients wi
Autor:
Jasmohan S Bajaj, Kelsey Miller, Jie Tan, Jonathan Lawrence, Norma Palma, Robert S Mittleman, Brian Meehan
Publikováno v:
Journal of Hepatology. 73:S721-S722
Autor:
John C. Burnett, Albert T. Profy, James E. Udelson, Robert S. Mittleman, Sanjiv J. Shah, Marvin A. Konstam, Jelena P. Seferovic, Gregory D. Lewis, David S. Reasner, Margaret M. Redfield, Michael R. Zile
Publikováno v:
American heart journal. 222
Background Heart failure with preserved ejection fraction (HFpEF) is a significant cause of morbidity and mortality worldwide. Exercise intolerance is the main symptom of HFpEF and is associated with a poor quality of life and increased mortality. Cu
Autor:
Yan Chen, Amy M. Gates, Robert S. Mittleman, James Z. Shao, Nimish Vakil, Michael F. Vaezi, Ronnie Fass, Lara Lane, Mark G. Currie, Michael Hall, David S. Reasner
Publikováno v:
Gastroenterology. 158(8)
Background & Aims Refractory gastroesophageal reflux disease (GERD) reduces quality of life and creates significant financial burden on the health care system. Approximately 30% of patients with GERD who receive label-dose proton pump inhibitors (PPI
Autor:
Zhaoyang Li, Walter Singleton, Rudy Gunawan, Robert S. Mittleman, Asif Mahmood, Rosie Z. Yu, John S. Grundy, Richard S. Geary, Yanfeng Wang
Publikováno v:
European Journal of Clinical Pharmacology. 72:267-275
The aim of this study to evaluate the effect of mipomersen on QT intervals in a phase I dose escalation, placebo-controlled study, and a thorough QT (tQT) study in healthy subjects. In the initial phase I study, 29 healthy subjects received either si
Autor:
Jelena P. Seferovic, Marvin A. Konstam, Margaret M. Redfield, Michael R. Zile, James E. Udelson, Robert S. Mittleman, John C. Burnett, Gregory D. Lewis, Sanjiv J. Shah, Albert T. Profy, Phebe J. Wilson, John D. Parker
Publikováno v:
Journal of Cardiac Failure. 26:S8
Introduction Heart failure with preserved ejection fraction (HFpEF) is associated with poor quality of life and increased mortality with exercise intolerance being the main symptom. Hypothesis The soluble guanylate cyclase (sGC) stimulator pralicigua
Autor:
Bal Raj Bhandari, Jeffrey Cehelsky, Yan Zheng, Mark Wingertzahn, Norma Palma, Robert S Mittleman
Publikováno v:
Journal of Hepatology. 73:S699
Autor:
James Z. Shao, Elizabeth P. Shea, Robert S. Mittleman, Mark G. Currie, Peter J. Kahrilas, Yan Chen
Publikováno v:
American Journal of Gastroenterology. 113:S227-S228